J Pharm Technol. 2017;33(4):156-166. doi: 10.1177/8755122517710671. Epub 2017 May 23.
Patterns of Statin Use in Older Medicare Beneficiaries With Traumatic Brain Injury.
The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians
Bilal Khokhar, Linda Simoni-Wastila, Julia F Slejko, Eleanor Perfetto, Min Zhan, Gordon S Smith
Affiliations
Affiliations
- University of Maryland, Baltimore, MD, USA.
- National Health Council, Washington, DC, USA.
- West Virginia University, Morgantown, WV, USA.
PMID: 29577114
PMCID: PMC5863738 DOI: 10.1177/8755122517710671
Abstract
BACKGROUND: In addition to lowering lipids, statins also may be beneficial for older adults sustaining a traumatic brain injury (TBI), as statin use prior to and following trauma may decrease mortality following injury. However, despite statins' potential to reduce mortality, there is limited research regarding statin use among older adults.
OBJECTIVE: To characterize and investigate factors associated with statin use among older adults with TBI.
METHODS: A retrospective drug utilization study was used to characterize statin use among Medicare beneficiaries 65 and older hospitalized with a TBI during 2006 to 2010 and with continuous Medicare Parts A, B, and D coverage 6 months prior and 12 months following TBI. Logistic regression was used to investigate the factors associated with statin use. The exposure of interest was statin use prior to and following TBI.
RESULTS: Of the 75 698 beneficiaries included in the study, 37 874 (~50%) of beneficiaries used a statin at least once during the study period. The most common statin used was simvastatin, while fluvastatin was the least used statin. Statin users were more likely to have cardiovascular diseases when compared to nonusers. Hyperlipidemia was a major factor associated with statin use and had the greatest impact on statin use compared to nonuse (odds ratio = 9.54; 95% confidence interval = 9.07, 10.03).
CONCLUSIONS: This national sample of older adults with TBI suggests that statins are commonly used. Future studies must next examine the impact of statin use on mortality and secondary injury in order to shape pharmacological therapy guidelines following TBI.
Keywords: cardiovascular drugs; drug utilization; geriatrics; pharmacoepidemiology; trauma medicine
Conflict of interest statement
Declaration of Conflicting Interests The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
References
- Health Aff (Millwood). 2009 Mar-Apr;28(2):w305-16 - PubMed
- J Am Coll Cardiol. 2008 Nov 25;52(22):1769-81 - PubMed
- J Trauma. 2011 Oct;71(4):815-9 - PubMed
- Neurotherapeutics. 2010 Jan;7(1):62-73 - PubMed
- Brain Inj. 2016;30(8):993-8 - PubMed
- Am J Geriatr Pharmacother. 2011 Dec;9(6):471-82 - PubMed
- PLoS Med. 2005 May;2(5):e123 - PubMed
- Ann Pharmacother. 2008 Sep;42(9):1208-15 - PubMed
- Clin Ther. 2006 Sep;28(9):1411-24; discussion 1410 - PubMed
- JAMA Intern Med. 2014 Aug;174(8):1244-51 - PubMed
- Brain Inj. 2013;27(13-14):1492-9 - PubMed
- Crit Care. 2013 May 29;17(3):227 - PubMed
- Handb Clin Neurol. 2015;127:343-66 - PubMed
- BMJ. 2009 Jun 30;338:b2376 - PubMed
- Nurs Crit Care. 2012 May-Jun;17(3):138-50 - PubMed
- Am J Cardiol. 2011 May 15;107(10):1409-14 - PubMed
- J Clin Med Res. 2013 Jun;5(3):168-73 - PubMed
- J Clin Psychiatry. 2016 Apr;77(4):505-11 - PubMed
- J Head Trauma Rehabil. 2015 Mar-Apr;30(2):E62-7 - PubMed
- Eur J Prev Cardiol. 2014 Apr;21(4):464-74 - PubMed
- J Trauma. 1996 Sep;41(3):380-6; discussion 386-8 - PubMed
- J Trauma. 2008 Jan;64(1):66-73; discussion 73-4 - PubMed
- J Am Coll Cardiol. 2013 Dec 24;62(25):2392-2394 - PubMed
- Am Heart J. 2008 Oct;156(4):662-73 - PubMed
- Arch Phys Med Rehabil. 2010 Jan;91(1):20-9 - PubMed
Publication Types
Grant support